n-acetyltryptophan has been researched along with Cardiometabolic Syndrome in 1 studies
N-acetyltryptophan : An N-acetylamino acid that is the N-acetyl derivative of tryptophan.
Cardiometabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components not only include metabolic dysfunctions of METABOLIC SYNDROME but also HYPERTENSION, and ABDOMINAL OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shim, K | 1 |
| Gulhar, R | 1 |
| Jialal, I | 1 |
1 other study available for n-acetyltryptophan and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Exploratory metabolomics of nascent metabolic syndrome.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Female; gamma-Amino | 2019 |